The Active Humidifier Devices Market generated USD 1,558.6 million in 2022 but is expected to face a gradual decline, with USD 1,264.4 million in revenue recorded in 2023. According to a recent report by Future Market Insights, the market is forecasted to contract further at a CAGR of -0.5%, reaching USD 1,206.9 million by 2033.
This downturn in growth is largely attributed to the shift in healthcare approaches, although obstructive respiratory diseases continue to drive demand for active humidifier devices. The market saw a notable surge in adoption during the historical period, particularly due to the outbreak of previously unknown infectious diseases, which placed heightened focus on respiratory system care.
Notably, invasive ventilation applications accounted for approximately 47% of total active humidifier device sales in 2022, highlighting their critical role in patient care for respiratory conditions. As the medical landscape evolves, the use of these devices in critical care settings remains essential.
Key Takeaways:
- Market Decline: The market is forecast to decrease from USD 1,558.6 million in 2022 to USD 1,206.9 million by 2033, driven by a negative growth trajectory of -0.5% CAGR.
- Ongoing Demand: The prevalence of obstructive respiratory diseases continues to drive the need for active humidifier devices.
- Invasive Ventilation: Active humidifiers used in invasive ventilation accounted for 47% of sales in 2022, underlining their importance in critical care.
- Healthcare Shifts: Despite the decline, active humidifier devices remain integral to respiratory support, especially in the context of severe respiratory conditions.
Long-term Strategies Adopted by Key Players to Sustain their Stance in the Market
Companies operating in the global active humidifier devices industry seek to invigorate their position through collaborations, partnerships, and agreements with established and emerging market players. Further, the acquisition significantly accelerates the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market.
Key Developments Taking Place in the Market:
- In January 2021, Vadi Medical Technology introduced a new humidifier – VH3000-220 Humidifier in addition to its existing range of humidifiers. This launch helped the company to strengthen its humidifier portfolio.
- Intersurgical Ltd., established its new office in Canada. With the establishment of its new subsidiary, the company has expanded its direct operations in Canada through which the products are expected to be available for hospitals in Canada.
- WILAmed GmbH introduced the AIRcon Gen2 Respiratory Humidifier, the next generation of respiratory humidifiers in 2019. From January 2019, AIRcon Gen 1 was discontinued and replaced by Gen2 humidifiers.
Market Dominance by Key Players in the Market
- Fisher & Paykel Healthcare Limited
- Koninklijke Philips N.V.(Philips Respironics)
- Vapotherm
- Teleflex Corporation
- ResMed Corporation
- VINCENT MEDICAL HOLDINGS LIMITED
- Armstrong Medical (an Eakin Company)
- Breas Medical AB (Subsidiary of Fosun Pharma)
- BMC Medical Co., Ltd
- Hamilton Medical AG
- SunMed
- WILAmed GmbH
- Flexicare (Group) Limited
- Penlon Limited
- DEAS S.R.L.
- Intersurgical Ltd
- Beijing Aeonmed Co., Ltd.
- Shenyang RMS MEDICAL TECH CO., LTD
- GaleMed Corporation
- Vadi Medical Technology Co, Ltd.
Full Report Revealed
Active Humidifier Devices by Category
By Product Type:
- Heated/electronic Humidifiers
- Bubble Humidifiers
- Accessories
By Age Group:
- Adult
- Pediatric
- Neonates
By Application:
- Invasive Ventilation
- Non-invasive Ventilation
- nCPAP (Nasal Continuous Positive Airway Pressure)
- Bubble CPAP (Bubble Continuous Positive Airway Pressure)
- High Flow Oxygen Therapy
By End User:
- Hospitals
- Less than 100 Beds
- 100-300 Beds
- 300-500 Beds
- 500 Beds and More
- Ambulatory Surgical Centers
- Sleep Centers
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube